Data / Research funding / Arizona / ST. Joseph's Hospital and Medical Center
ST. Joseph's Hospital and Medical Center: 39 NIH awards ($96.9M), fiscal years 2021 to 2026
ST. Joseph's Hospital and Medical Center in Phoenix, AZ is funded under 39 NIH awards ($96.9M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- SKX6AXF9ZTM3
- State
- Arizona
Awards
39 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| Neurobiology of Mild Cognitive Impairment in the Elderly | NIH | National Institute on Aging | 2021 to 2024 | $9,576,598 | September 1, 1997 | March 31, 2026 | MUFSON, ELLIOTT JAY | reporter.nih.gov |
| Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,229,195 | September 1, 2021 | August 31, 2027 | SATTLER, RITA | reporter.nih.gov |
| A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,799,271 | May 5, 2021 | April 30, 2027 | JHA, RUCHIRA MENKA | reporter.nih.gov |
| Default mode network dysfunction in Down Syndrome | NIH | National Institute on Aging | 2023 | $1,844,755 | April 15, 2023 | March 31, 2026 | MUFSON, ELLIOTT JAY | reporter.nih.gov |
| Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | NIH | National Institute on Aging | 2023 to 2025 | $1,814,797 | June 1, 2023 | February 29, 2028 | HASHIMOTO, TOMOKI | reporter.nih.gov |
| Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor LKB1 in Exosomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,649,563 | June 15, 2022 | May 31, 2027 | MOHANAKUMAR, THALACHALLOUR | reporter.nih.gov |
| Diffusion MRI Biomarkers of Peripheral Nerve Trauma | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,622,655 | May 1, 2023 | April 30, 2025 | DORTCH, RICHARD | reporter.nih.gov |
| Multi-scale functional connectivity in preclinical models of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,585,539 | January 1, 2022 | November 30, 2026 | STOKES, ASHLEY M | reporter.nih.gov |
| An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | NIH | National Institute on Aging | 2024 to 2025 | $1,585,301 | September 1, 2024 | May 31, 2029 | PHUAH, CHIA-LING | reporter.nih.gov |
| Mechanisms for intracranial aneurysm rupture | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,537,702 | December 1, 2019 | November 30, 2025 | HASHIMOTO, TOMOKI | reporter.nih.gov |
| Imaging Biomarkers of Neurotoxicity in Welders | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $1,523,587 | February 11, 2023 | June 30, 2026 | RACETTE, BRAD A | reporter.nih.gov |
| Repurposing Siponimod for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2023 | $1,375,960 | August 15, 2021 | July 31, 2027 | SABBAGH, MARWAN NOEL | reporter.nih.gov |
| MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients | NIH | National Institute on Aging | 2022 to 2023 | $1,365,602 | September 1, 2018 | May 31, 2025 | SABBAGH, MARWAN NOEL | reporter.nih.gov |
| EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,313,346 | September 30, 2019 | August 31, 2025 | HASHIMOTO, TOMOKI | reporter.nih.gov |
| South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,170,748 | September 1, 2024 | June 30, 2029 | RACETTE, BRAD A | reporter.nih.gov |
| Endothelial complement C3a receptor mediated cerebral injury in a murine stroke model. | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $853,135 | September 1, 2024 | August 31, 2029 | DUCRUET, ANDREW FREDERICK | reporter.nih.gov |
| Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | NIH | National Cancer Institute | 2024 to 2025 | $812,274 | July 1, 2024 | June 30, 2027 | STOKES, ASHLEY M | reporter.nih.gov |
| Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $809,219 | December 1, 2021 | July 31, 2022 | QUARLES, CHRISTOPHER CHAD | reporter.nih.gov |
| Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ Dementia | NIH | National Institute on Aging | 2021 to 2022 | $790,638 | May 1, 2018 | November 30, 2024 | GEDA, YONAS E | reporter.nih.gov |
| Establishing the validity of brain tumor perfusion imaging | NIH | National Cancer Institute | 2021 to 2022 | $714,665 | July 3, 2017 | July 31, 2022 | QUARLES, CHRISTOPHER CHAD | reporter.nih.gov |
| Establishing the clinical utility of a consensus DSC-MRI Protocol | NIH | National Cancer Institute | 2022 | $681,274 | March 1, 2022 | July 31, 2022 | QUARLES, CHRISTOPHER CHAD | reporter.nih.gov |
| Barrow Neurological Institute application to become a NeuroNEXT site. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $648,934 | July 15, 2018 | June 30, 2024 | SHEFNER, JEREMY M | reporter.nih.gov |
| Manganese-Induced Neurotoxic Effects Research in South Africa | NIH | National Institute of Environmental Health Sciences | 2021 | $623,956 | March 25, 2023 | August 31, 2024 | RACETTE, BRAD A | reporter.nih.gov |
| Astrocyte regulation of cortical neurodegeneration in C9orf72 FTD/ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $502,724 | September 29, 2021 | March 19, 2024 | SATTLER, RITA | reporter.nih.gov |
| A Single Cell and Proteomic Precision Medicine Approach to Glyburide Responsive Contusion Expansion in Severe Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $479,542 | April 15, 2023 | March 31, 2026 | JHA, RUCHIRA MENKA | reporter.nih.gov |
| NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY | NIH | National Institute of Environmental Health Sciences | 2023 | $475,542 | September 12, 2019 | May 31, 2025 | CRISWELL, SUSAN | reporter.nih.gov |
| Transcriptomic assessment of pathology in PD with dementia and dementia with Lewy Bodies using iPSC neurons and brain tissue of the same individuals | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $423,274 | August 15, 2022 | July 31, 2025 | SATTLER, RITA | reporter.nih.gov |
| Investigating the role of cerebral perfusion in demyelination and repair in multiple sclerosis with MRI | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $421,988 | June 1, 2022 | May 31, 2025 | STOKES, ASHLEY M | reporter.nih.gov |
| MRI Assessment of Tumor Perfusion, Permeability and Cellularity | NIH | National Cancer Institute | 2021 | $399,483 | September 16, 2011 | November 30, 2022 | QUARLES, CHRISTOPHER CHAD | reporter.nih.gov |
| Prototoxin Effects on Nicotinic Receptor Function | NIH | National Institute on Drug Abuse | 2021 | $376,119 | April 1, 2018 | November 22, 2021 | WHITEAKER, PAUL | reporter.nih.gov |
| Alpha-synuclein aggregation disrupts motility, synaptic transmission, and calcium signaling in the myenteric plexus of the rat colon | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $367,016 | February 1, 2017 | January 31, 2024 | MANFREDSSON, FREDRIC | reporter.nih.gov |
| Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | NIH | National Cancer Institute | 2021 | $347,723 | July 1, 2020 | August 31, 2023 | STOKES, ASHLEY M | reporter.nih.gov |
| Mechanisms of A-I RNA editing-mediated nuclear export of TDP-43 | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $345,566 | September 22, 2022 | August 31, 2025 | SATTLER, RITA | reporter.nih.gov |
| Does perfluorocarbon attenuate the severity of SAH by limiting vasospasm and improving tissue oxygenation? | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $204,416 | July 15, 2021 | March 4, 2022 | AHMAD, ABDULLAH S | reporter.nih.gov |
| Translational assessment of sulfonylurea receptor-1 as a biomarker and therapeutic target for cerebral edema in traumatic brain injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $188,729 | June 15, 2017 | May 31, 2023 | JHA, RUCHIRA MENKA | reporter.nih.gov |
| Circadian Regulation of the Dorsomedial Hypothalamic Nucleus and Its Impact on Energy Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $135,494 | December 1, 2021 | November 30, 2023 | FABER, CHELSEA LEIGH | reporter.nih.gov |
| Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $45,724 | August 13, 2025 | February 13, 2028 | ONDATJE, BRIANA | reporter.nih.gov |
| Characterization of amyloid-β:α7β2-nicotinic acetylcholine receptor interactions relevant to Alzheimer's disease | NIH | National Institute on Aging | 2021 | $10,241 | September 15, 2020 | November 4, 2021 | GEORGE, ANDREW ANTHONY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 10 | $24,797,321 | 0 | $0 |
| 2024 | 15 | $24,106,080 | 0 | $0 |
| 2023 | 18 | $28,299,311 | 0 | $0 |
| 2022 | 19 | $10,919,833 | 0 | $0 |
| 2021 | 18 | $8,733,190 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Neurosciences
- Brain Disorders
- Clinical Research
- Neurodegenerative
- Biomedical Imaging
- Acquired Cognitive Impairment
- Aging
- Dementia
- Rare Diseases
- Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
- Genetics
- Clinical Trials and Supportive Activities
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.